Sage Journals: Discover world-class research

Abstract

Background

B-type natriuretic peptides (BNP) and cardiac enzymes are both recognized biomarkers of heart health. Many studies have reported that using these indicators can assess cardiac condition and predict prognosis of patients undergoing surgery. Currently little is known on the effect of increased cardiac input after venous recanalization on cardiac physiology in patients with chronic venous obstruction (CVO).

Objectives

The aim of this study was to explore the effect of iliocaval recanalization and stenting on cardiac biomarkers in patients with CVO.

Methods

This was a prospective study involving 60 patients in a single unit. Blood tests were collected 1 day before and 1 day after venous intervention. Three groups as group 1: patients with iliofemoral post-thrombotic syndrome (PTS) but without involvement of inferior vena cava (IVC) (n = 33); group 2: patients with iliofemoral PTS and involvement of IVC (n = 19) and group 3: patients with non-thrombotic vein lesion (NIVL) (n = 8) were compared based on cardiac biomarker levels.

Results

Median concentration of post-operative BNP (259.60 pg/mL) was greater than preoperative levels (49.80 pg/mL) [interquartile range (IQR), 147.15/414.68 versus 29.85/82.88; p < 0.001]. The levels of CK-MB [preop: 3 U/l (IQR, 1.40/11.00) versus postop: 14 U/l (IQR, 12/17), p < 0.001] and troponin T [preop: 3.00 pg/mL (IQR, 3.00/5.25) versus postop: level of 6 pg/mL (IQR, 3.00/9.50), p < 0.001]. Post-procedure increases in cardiac enzymes showed significant differences in BNP (p = 0.023) and troponin T (p = 0.007) across the three groups, while CK-MB levels were not significantly different (p > 0.05). Intergroup comparisons of postoperative BNP: group 1 versus group 2 (p = 0.013), group 2 versus group 3 (p = 0.029), group 1 versus group 3 (p = 0.834); and postoperative troponin T: group 1 versus group 2 (p = 0.018), group 2 versus group 3 (p = 0.002), group 1 versus group 3 (p = 0.282). According to multiple linear regression analysis, length of stenting and level of preoperative BNP were independent determinants of postoperative BNP levels (p < 0.05), and preoperative troponin T affected postoperative troponin T independently (p < 0.05).

Conclusions

Troponin T, CK-MB and BNP seem to increase after venous recanalization and stent implantation, the elevation being more prominent for longer lesions.

Keywords

Chronic venous obstruction recanalization venous return B-type natriuretic peptides cardiac enzymes

Get full access to this article

View all access options for this article.

References

Kahn

Comerota

Cushman

American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing , et al.. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 2014; 130(18): 1636–1661.

Badesha

Bains

PRS

Bains

BRS

, et al. A systematic review and meta-analysis of the treatment of obstructive chronic deep venous disease using dedicated venous stents. J Vasc Surg Venous Lymphat Disord 2022; 10(1): 267–282.e4.

de Wolf

de Graaf

Kurstjens

, et al. Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg 2015; 50(4): 518–526.

Razavi

Jaff

Miller

. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis. Circ Cardiovasc Interv 2015; 8(10): e002772.

Rowell

. Reflex control of regional circulations in humans. J Auton Nerv Syst 1984; 11(2): 101–114.

Normahani

Shalhoub

Narayanan

. Repurposing the systemic venous return model for conceptualisation of chronic venous insufficiency and its management. Phlebology 2020; 35(10): 749–751.

Coelho

O’Sullivan

. Evaluation of incidence and clinical significance of obturator hook sign as a marker of chronic iliofemoral venous outflow obstruction in computed tomography venography. J Vasc Surg Venous Lymphat Disord 2020; 8(2): 237–243.

Kurstjens

de Wolf

van Laanen

, et al. Hemodynamic significance of collateral blood flow in chronic venous obstruction. Phlebology 2015; 30(1 Suppl): 27–34.

Morris

Sobotka

Balmforth

, et al. Iliocaval venous obstruction, cardiac preload reserve and exercise limitation. J Cardiovasc Transl Res 2020; 13(4): 531–539.

10.

Krauser

Lloyd-Jones

Chae

, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 2005; 149(4): 744–750.

11.

van Kimmenade

Januzzi

Jr. Bakker

, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol 2009; 53(10): 884–890.

12.

Cowie

Jourdain

Maisel

, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003; 24(19): 1710–1718.

13.

Redfield

Rodeheffer

Jacobsen

, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40(5): 976–982.

14.

Saul

Shatzer

. B-type natriuretic peptide testing for detection of heart failure. Crit Care Nurs Q 2003; 26(1): 35–39.

15.

Pemberton

Johnson

Yandle

, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000; 36(3): 355–359.

16.

Kucher

Printzen

Goldhaber

. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107(20): 2545–2547.

17.

Liebetrau

Gaede

Dorr

, et al. Reference values and release kinetics of B-type natriuretic peptide signal peptide in patients with acute myocardial infarction. Clin Chem 2015; 61(12): 1532–1539.

18.

Hoksch

Fahrner

, et al. Procalcitonin and brain natriuretic peptide as parameters in the postoperative course of patients with major pulmonary resection. Interact Cardiovasc Thorac Surg 2007; 6(2): 155–159.

19.

Vetrugno

Langiano

Gisonni

, et al. Prediction of early postoperative major cardiac events after elective orthopedic surgery: the role of B-type natriuretic peptide, the revised cardiac risk index, and ASA class. BMC Anesthesiol 2014; 14: 20.

20.

Mahla

Baumann

Rehak

, et al. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology 2007; 106(6): 1088–1095.

21.

Rajagopalan

Croal

Reeve

, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up. Eur J Vasc Endovasc Surg 2011; 41(5): 657–662.

22.

Suttie

Mofidi

McCallum

, et al. Immediately postoperative B-type natriuretic peptide and its predictive value. Ann Vasc Surg 2011; 25(2): 248–255.

23.

Matsumura

Brewster

Makaroun

, et al. A multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysm. J Vasc Surg 2003; 37(2): 262–271.

24.

Sato

Takahashi

Mikamo

, et al. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention. Heart Ves 2020; 35(12): 1664–1671.

25.

Wayne Causey

Singh

. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient. Semin Vasc Surg 2014; 27(3-4): 143–147.

26.

Gaggin

Januzzi

Jr . Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013; 1832(12): 2442–2450.

27.

Yamanouchi

Kudo

Endo

, et al. Blood N-terminal proBNP as a potential indicator of cardiac preload in patients with high volume load. Tohoku J Exp Med 2010; 221(3): 175–180.

28.

Weil

Suzuki

Young

, et al. Troponin release and reversible left ventricular dysfunction after transient pressure overload. J Am Coll Cardiol 2018; 71(25): 2906–2916.

29.

Nielsen

Fabricius

. The blood flow in the caval veins at rest and during exercise in normal subjects. Acta Med Scand 1968; 183(1-2): 97–99.

30.

Miller

Staats

. Impaired exercise tolerance after inferior vena caval interruption. Chest 1988; 93(4): 776–780.

31.

Pellicori

Carubelli

Zhang

, et al. IVC diameter in patients with chronic heart failure: relationships and prognostic significance. JACC Cardiovasc Imaging 2013; 6(1): 16–28.

32.

Griffin

Ivey-Miranda

McCallum

, et al. Inferior vena cava diameter measurement provides distinct and complementary information to right atrial pressure in acute decompensated heart failure. J Card Fail 2022; 28(7): 1217–1221.

33.

Cilli

Alibhai

Armitage-Chan

, et al. Incidence of elevation of cardiac troponin I prior to and following routine general anaesthesia in dogs. Vet Anaesth Analg 2010; 37(5): 409–416.

34.

Mair

Lindahl

Hammarsten

, et al.

How is cardiac troponin released from injured myocardium?

Eur Heart J Acute Cardiovasc Care 2018; 7(6): 553–560.

35.

Aengevaeren

Baggish

Chung

, et al. Exercise-Induced cardiac troponin elevations: from underlying mechanisms to clinical relevance. Circulation 2021; 144(24): 1955–1972.

36.

Baker

Leckie

Harrington

, et al. Exercise-induced cardiac troponin elevation: an update on the evidence, mechanism and implications. Int J Cardiol Heart Vasc 2019; 22: 181–186.

37.

Thygesen

Alpert

Jaffe

, et al. Third universal definition of myocardial infarction. Circulation 2012; 126(16): 2020–2035.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

Elevation of cardiac enzymes and B-type natriuretic peptides following venous recanalization and stenting in chronic venous obstruction